Abstract:Klebsiella pneumoniae is one of the most common nosocomial opportunistic pathogens and usually exhibits multiple-drug resistance. Phage therapy, a potential therapeutic to replace or supplement antibiotics, has attracted much attention. However, very few Klebsiella phages have been well characterized because of the lack of efficient genome-editing tools. Here, Cas9 from Streptococcus pyogenes and a single guide RNA (sgRNA) were used to modify a virulent Klebsiella bacteriophage, phiKpS2. We first evaluated the distribution of sgRNA activity in phages and proved that it is largely inconsistent with the predicted activity from current models trained on eukaryotic cell data sets. A simple CRISPR-based phage genome-editing procedure was developed based on the discovery that homologous arms as short as 30 to 60 bp were sufficient to introduce point mutation, gene deletion, and swap. We also demonstrated that weak sgRNAs could be used for precise phage genome editing but failed to select random recombinants, possibly because inefficient cleavage can be tolerated through continuous repair by homologous recombination with the uncut genomes. Small frameshift deletion was proved to be an efficient way to evaluate the essentiality of phage genes. By using the abovementioned strategies, a putative promoter and nine genes of phiKpS2 were successfully deleted. Interestingly, the holin gene can be deleted with little effect on phiKpS2 infection, but the reason is not yet clear. This study established an efficient, time-saving, and cost-effective procedure for phage genome editing, which is expected to significantly promote the development of bacteriophage therapy. IMPORTANCE In the present study, we have addressed efficient, time-saving, and cost-effective CRISPR-based phage genome editing of Klebsiella phage, which has the potential to significantly expand our knowledge of phage-host interactions and to promote applications of phage therapy. The distribution of sgRNA activity was first evaluated in phages. Short homologous arms were proven to be enough to introduce point mutation, small frameshift deletion, gene deletion, and swap into phages, and weak sgRNAs were proven useful for precise phage genome editing but failed to select random recombinants, all of which makes the CRISPR-based phage genome-editing method easier to use.

CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage K

Efficient genome engineering of a virulent bacteriophage using CRISPR-Cas9.

Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10

Computational pipeline for targeted integration and variable payload expression for bacteriophage engineering.

Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions

Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria

Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering

Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.

Bacteriophage-resistant industrial fermentation strains: from the cradle to CRISPR/Cas9

Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia

CRISPR Gene Editing of a Virulent Bacteriophage

A functional type II-A CRISPR–Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage

A Programmable CRISPR/Cas9-based Phage Defense System for Escherichia Coli BL21(DE3)

CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus.

Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics

Engineered bacteriophages: A panacea against pathogenic and drug resistant bacteria

Transcription modulation of pathogenic streptococcal and enterococcal species using CRISPRi technology

Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages

Experimental Phage Evolution Results in Expanded Host Ranges Against MDR and XDR Klebsiella pneumoniae Isolates

Engineering T4 Bacteriophage for In Vivo Display by Type V CRISPR-Cas Genome Editing

[Editing of Phage Genomes - Recombineering-Assisted SpCas9 Modification of Model Coliphages T7, T5, and T3]